Zentalis Pharmaceuticals, Inc. - common stock — Quarterly Cash Flow (NASDAQ:ZNTL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 384.02 M351.71 M327.25 M288.97 M253.07 M Total liabilities 88.64 M77.21 M74.38 M72.76 M70.39 M Total equity 295.38 M274.5 M252.87 M216.2 M182.68 M Total liabilities & shareholders' equities 384.02 M351.71 M327.25 M288.97 M253.07 M Total debt ————— Net debt —————

News

ZNTL Stock Rises 28% in 3 Months: What's Driving the Rally?

What's Behind The Surge In Zentalis Stock? - Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Wells Fargo assumes coverage on Zentalis stock with $5 target

Zentalis Pharma CEO Eastland sells $21k in shares

Zentalis Pharma CMO Bruns sells $7998 in stock

Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)

Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners

Zentalis to present azenosertib data at cancer therapeutics conference

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update